Mesarem contains mesalamine prolonged release tablets IP 1200 mg. Mesalamine is an anti-inflammatory medication used as a first-line treatment in the management of mild to moderate ulcerative colitis. It is safe, effective and well tolerated treatment in mild to moderate active ulcerative colitis. Dosage: Two to four 1.2 g tablets to be taken once daily with meal for a total daily dose of 2.4 g or 4.8 g